Li Yan M, Pan Yong, Wei Yongkun, Cheng Xiaoyun, Zhou Binhua P, Tan Ming, Zhou Xiaoyan, Xia Weiya, Hortobagyi Gabriel N, Yu Dihua, Hung Mien-Chie
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Cancer Cell. 2004 Nov;6(5):459-69. doi: 10.1016/j.ccr.2004.09.027.
The receptor tyrosine kinase HER2 enhances tumor metastasis; however, its role in homing to metastatic organs is poorly understood. The chemokine receptor CXCR4 has recently been shown to mediate the movement of malignant cancer cells to specific organs. Here, we show that HER2 enhances the expression of CXCR4, which is required for HER2-mediated invasion in vitro and lung metastasis in vivo. HER2 also inhibits ligand-induced CXCR4 degradation. Finally, a significant correlation between HER2 and CXCR4 expression was observed in human breast tumor tissues, and CXCR4 expression correlated with a poor overall survival rate in patients with breast cancer. These results provide a plausible mechanism for HER2-mediated breast tumor metastasis and establish a functional link between HER2 and CXCR4 signaling pathways.
受体酪氨酸激酶HER2可促进肿瘤转移;然而,其在归巢至转移器官中的作用却鲜为人知。趋化因子受体CXCR4最近被证明可介导恶性癌细胞向特定器官的移动。在此,我们表明HER2可增强CXCR4的表达,而CXCR4是HER2介导的体外侵袭和体内肺转移所必需的。HER2还可抑制配体诱导的CXCR4降解。最后,在人乳腺肿瘤组织中观察到HER2与CXCR4表达之间存在显著相关性,且CXCR4表达与乳腺癌患者较差的总生存率相关。这些结果为HER2介导的乳腺肿瘤转移提供了一种合理的机制,并在HER2与CXCR4信号通路之间建立了功能联系。